312 related articles for article (PubMed ID: 23910080)
1. Will SCNT-ESCs be better than iPSCs for personalized regenerative medicine?
Sancho-Martinez I; Izpisua Belmonte JC
Cell Stem Cell; 2013 Aug; 13(2):141-2. PubMed ID: 23910080
[No Abstract] [Full Text] [Related]
2. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
[TBL] [Abstract][Full Text] [Related]
3. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
[TBL] [Abstract][Full Text] [Related]
4. Comparison of reprogramming genes in induced pluripotent stem cells and nuclear transfer cloned embryos.
Duan L; Wang Z; Shen J; Shan Z; Shen X; Wu Y; Sun R; Li T; Yuan R; Zhao Q; Bai G; Gu Y; Jin L; Lei L
Stem Cell Rev Rep; 2014 Aug; 10(4):548-60. PubMed ID: 24828831
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells: progress and future perspectives in the stem cell world.
Rezanejad H; Matin MM
Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654
[TBL] [Abstract][Full Text] [Related]
6. Enhanced telomere rejuvenation in pluripotent cells reprogrammed via nuclear transfer relative to induced pluripotent stem cells.
Le R; Kou Z; Jiang Y; Li M; Huang B; Liu W; Li H; Kou X; He W; Rudolph KL; Ju Z; Gao S
Cell Stem Cell; 2014 Jan; 14(1):27-39. PubMed ID: 24268696
[TBL] [Abstract][Full Text] [Related]
7. Somatic cell nuclear transfer-derived embryonic stem cell lines in humans: pros and cons.
Langerova A; Fulka H; Fulka J
Cell Reprogram; 2013 Dec; 15(6):481-3. PubMed ID: 24180743
[TBL] [Abstract][Full Text] [Related]
8. How far are induced pluripotent stem cells from the clinic?
Li M; Chen M; Han W; Fu X
Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
[TBL] [Abstract][Full Text] [Related]
9. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
Pan G; Wang T; Yao H; Pei D
Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs.
Kim E; Hyun SH
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626414
[TBL] [Abstract][Full Text] [Related]
11. Ovine induced pluripotent stem cells are resistant to reprogramming after nuclear transfer.
German SD; Campbell KH; Thornton E; McLachlan G; Sweetman D; Alberio R
Cell Reprogram; 2015 Feb; 17(1):19-27. PubMed ID: 25513856
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.
Choi HW; Kim JH; Chung MK; Hong YJ; Jang HS; Seo BJ; Jung TH; Kim JS; Chung HM; Byun SJ; Han SG; Seo HG; Do JT
Stem Cells Dev; 2015 Jun; 24(11):1366-73. PubMed ID: 25590788
[TBL] [Abstract][Full Text] [Related]
13. Concise Review: Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer: A Horse in the Race?
Wolf DP; Morey R; Kang E; Ma H; Hayama T; Laurent LC; Mitalipov S
Stem Cells; 2017 Jan; 35(1):26-34. PubMed ID: 27612640
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
15. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic cloning and cellular reprogramming.
Rodriguez RM; Ross PJ; Cibelli JB
Adv Exp Med Biol; 2012; 741():276-89. PubMed ID: 22457116
[TBL] [Abstract][Full Text] [Related]
17. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
Anastasia L; Pelissero G; Venerando B; Tettamanti G
Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
[TBL] [Abstract][Full Text] [Related]
18. Molecular and functional resemblance of differentiated cells derived from isogenic human iPSCs and SCNT-derived ESCs.
Zhao MT; Chen H; Liu Q; Shao NY; Sayed N; Wo HT; Zhang JZ; Ong SG; Liu C; Kim Y; Yang H; Chour T; Ma H; Gutierrez NM; Karakikes I; Mitalipov S; Snyder MP; Wu JC
Proc Natl Acad Sci U S A; 2017 Dec; 114(52):E11111-E11120. PubMed ID: 29203658
[TBL] [Abstract][Full Text] [Related]
19. Advances in cell lineage reprogramming.
Zhou J; Yue W; Pei X
Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
[TBL] [Abstract][Full Text] [Related]
20. Impaired neural differentiation potency by retinoic acid receptor-α pathway defect in induced pluripotent stem cells.
Hou PS; Huang WC; Chiang W; Lin WC; Chien CL
Cell Reprogram; 2014 Dec; 16(6):467-76. PubMed ID: 25364979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
